REG - ADVFN PLC - Corporate update

ADVFNAnnouncement

28/11/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221128:nRSb6875Ha&default-theme=true

RNS Number : 6875H  ADVFN PLC  28 November 2022

28 November 2022
For immediate release
ADVFN PLC

("ADVFN" or the "Company")

Corporate Update

 

Further to the announcement of the Board composition on 19 August 2022, the
Company announces that with immediate effect Amit Tauman has been appointed
Chief Executive. Jon Mullins, who had been acting Chief Executive, has
reverted to his roles of Chief Financial and Technology Officer.

 

Following these latest appointments, the Board composition is now as follows:

 

 Lord Gold           Non-executive Chairman
 Amit Tauman         Chief Executive
 Jon Mullins         Chief Financial and Technology Officer
 Matt Collom         Executive Director (sales)
 Anthony Wollenberg  Non-executive Director

 

Enquiries:

 

For further information please contact:

 ADVFN PLC                                                  +44 (0) 203 8794 460

 Jonathan Mullins
 Beaumont Cornish Limited (Nominated Adviser)

 www.beaumontcornish.com (http://www.beaumontcornish.com)
 Roland Cornish/Michael Cornish                             +44 (0) 207 628 3396

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the
European Union (Withdrawal) Act 2018. The person who arranged for the release
of this announcement on behalf of the Company was Amit Tauman, Director.

 

A copy of this announcement will be available on the Group's website:

 www.advfnplc.com (http://www.advfnplc.com)

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDDELFLLFLFFBB